This Biotech Just Edited RNA — And Shares Hit The Stratosphere
Shares of Wave Life Sciences (WVE) surged to a four-year high Wednesday after the company announced "impressive" proof-of-concept results for its new technology in two patients with a genetic disease. The biotech company tested its experimental …